Chesapeake Wealth Management Laboratory Corp Of America Holdings Transaction History

Chesapeake Wealth Management

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2023 Nov 16, 2023	SELL	$201.05 - $221.7 $11,660 - $12,858	-58 Reduced 4.28%	1,297 $260,000
Q1 2023 Apr 25, 2023	SELL	$213.32 - $257.83 $24,745 - $29,908	-116 Reduced 7.89%	1,355 $310,000
Q4 2022 Feb 23, 2023	SELL	$203.72 - $248.97 $17,112 - $20,913	-84 Reduced 5.4%	1,471 $346,000
Q3 2022 Oct 28, 2022	SELL	$204.81 - $262.19 $2,048 - $2,621	-10 Reduced 0.64%	1,555 $318,000
Q1 2022 Apr 19, 2022	SELL	$259.82 - $298.18 $2,598 - $2,981	-10 Reduced 0.63%	1,565 $412,000
Q3 2021 Oct 26, 2021	SELL	$274.82 - $308.34 $43,421 - $48,717	-158 Reduced 9.12%	1,575 $443,000
Q2 2021 Jul 29, 2021	SELL	$251.87 - $278.14 $15,112 - $16,688	-60 Reduced 3.35%	1,733 $478,000
Q1 2021 Apr 26, 2021	SELL	$204.88 - $255.03 $2,458 - $3,060	-12 Reduced 0.66%	1,793 $458,000
Q3 2020 Nov 12, 2020	SELL	$167.03 - $201.3 $6,347 - $7,649	-38 Reduced 2.06%	1,805 $340,000
Q4 2019 Jan 29, 2020	SELL	$163.48 - $173.61 $12,261 - $13,020	-75 Reduced 3.91%	1,843 $312,000
Q3 2019 Oct 25, 2019	SELL	$159.77 - $178.1 $7,988 - $8,905	-50 Reduced 2.54%	1,918 $322,000
Q2 2019 Aug 01, 2019	SELL	$144.16 - $172.9 $37,481 - $44,954	-260 Reduced 11.67%	1,968 $340,000
Q1 2019 Apr 17, 2019	SELL	$123.7 - $156.3 $19,173 - $24,226	-155 Reduced 6.5%	2,228 $341,000
Q4 2018 Feb 06, 2019	SELL	$120.82 - $174.09 $26,580 - $38,299	-220 Reduced 8.45%	2,383 $301,000
Q2 2018 Aug 07, 2018	SELL	$160.33 - $189.41 $31,585 - $37,313	-197 Reduced 7.04%	2,603 $467,000
Q1 2018 Jun 04, 2018	BUY	$161.53 - $178.11 $452,284 - $498,708	2,800 New	2,800 $453,000

1.94M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $20.6B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Chesapeake Wealth Management, based on Form 13F filings with the SEC.

Stay updated on Chesapeake Wealth Management with notifications on news.